These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 17511335)

  • 1. Hormone therapy in perimenopausal and postmenopausal women: examining the evidence on cardiovascular disease risks.
    Plonczynski DJ; Plonczynski KJ
    J Gerontol Nurs; 2007 May; 33(5):48-55. PubMed ID: 17511335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long term hormone therapy for perimenopausal and postmenopausal women.
    Marjoribanks J; Farquhar C; Roberts H; Lethaby A
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormone therapy in postmenopausal and perimenopausal women.
    Magee SR; Taylor JS
    Am Fam Physician; 2006 Nov; 74(9):1501-3. PubMed ID: 17111886
    [No Abstract]   [Full Text] [Related]  

  • 5. Climacteric medicine: European Menopause and Andropause Society (EMAS) 2004/2005 position statements on peri- and postmenopausal hormone replacement therapy.
    Skouby SO; Al-Azzawi F; Barlow D; Calaf-Alsina Erdogan Ertüngealp J; Gompel A; Graziottin A; Hudita D; Pines A; Rozenberg S; Samsioe G; Stevenson JC;
    Maturitas; 2005 May; 51(1):8-14. PubMed ID: 15883103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary prevention of cardiovascular disease with hormone replacement therapy.
    Schierbeck L
    Climacteric; 2015; 18(4):492-7. PubMed ID: 25830825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.
    Dumanski SM; Ramesh S; James MT; Metcalfe A; Nerenberg K; Seely EW; Robertson HL; Ahmed SB
    Syst Rev; 2017 Jul; 6(1):134. PubMed ID: 28683787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Risk of Cardiovascular Disease, Fracture, Dementia, and Cancer After Long-Term Hormone Therapy in Perimenopausal and Postmenopausal Women.
    Van Leer P
    Am Fam Physician; 2018 Jul; 98(2):117-118. PubMed ID: 30215990
    [No Abstract]   [Full Text] [Related]  

  • 10. Long term hormone therapy for perimenopausal and postmenopausal women.
    Farquhar CM; Marjoribanks J; Lethaby A; Lamberts Q; Suckling JA;
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004143. PubMed ID: 16034922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of hormone replacement therapy in postmenopausal women.
    Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
    J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone therapy update. How to make sense of the new recommendations on postmenopausal hormone therapy.
    Harv Womens Health Watch; 2013 Mar; 20(7):3. PubMed ID: 23862210
    [No Abstract]   [Full Text] [Related]  

  • 13. Postmenopausal hormone replacement therapy for the primary prevention of chronic conditions: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 Jun; 103(6):83-91. PubMed ID: 12802162
    [No Abstract]   [Full Text] [Related]  

  • 14. Breast cancer after hormone replacement therapy--does prognosis differ in perimenopausal and postmenopausal women?
    Baumgärtner AK; Häusler A; Seifert-Klauss V; Schuster T; Schwarz-Boeger U; Kiechle M
    Breast; 2011 Oct; 20(5):448-54. PubMed ID: 21652211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmenopausal hormone replacement and cardiovascular disease: incorporating research into practice.
    Chase SK; Youngkin EQ
    J Obstet Gynecol Neonatal Nurs; 2004; 33(5):648-56. PubMed ID: 15495711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of menopausal hormone therapy in the prevention and treatment of low bone density in perimenopausal and postmenopausal women.
    Shah N; Ariel D
    Curr Opin Obstet Gynecol; 2023 Apr; 35(2):141-149. PubMed ID: 36912327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review.
    Depypere H; Inki P
    Climacteric; 2015; 18(4):470-82. PubMed ID: 25553775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postmenopausal hormone replacement therapy--clinical implications.
    Ravn SH; Rosenberg J; Bostofte E
    Eur J Obstet Gynecol Reprod Biol; 1994 Feb; 53(2):81-93. PubMed ID: 8194655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.